Von dem Buch Tuberculosis and the Tubercle Bacillus Jr. Editor haben wir 4 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: William R. Jacobs: Tuberculosis and the Tubercle Bacillus Jr. Editor (ISBN: 9781683673057) in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
64%: Editor: Stewart T. Cole, Editor: Kathleen Davis Eisenach, Editor: David N. McMurray, Editor: William R. Jr. Jacobs: Tourismuspsychologie (ISBN: 9781555812959) 2004, Erstausgabe, in Englisch, Broschiert.Nur diese Ausgabe anzeigen…
55%: William R., Jr., Ed. Jacobs: Tuberculosis And The Tubercle Bacillus (ISBN: 9781555819552) 2017, 2. Ausgabe, in Englisch, Broschiert.Nur diese Ausgabe anzeigen…
55%: William R. Jacobs: Tuberculosis and the Tubercle Bacillus (ISBN: 9781555819569) John Wiley & Sons, in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
Tuberculosis and the Tubercle Bacillus Jr. Editor - 14 Angebote vergleichen
Bester Preis: € 95,27 (vom 05.03.2020)1
Symbolbild
Tuberculosis and the Tubercle Bacillus (2004)
EN HCISBN: 9781555812959 bzw. 1555812953, in Englisch, ASM Press, gebundenes Buch.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Troškove transporta do: BIH.
Von Händler/Antiquariat, Anybook Ltd.
ASM Press, 2004. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. , 1700grams, ISBN:9781555812959.
Von Händler/Antiquariat, Anybook Ltd.
ASM Press, 2004. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. , 1700grams, ISBN:9781555812959.
2
Tuberculosis and the Tubercle Bacillus William R. Jacobs Jr. Editor
~EN NW EB DLISBN: 9781683673057 bzw. 1683673050, vermutlich in Englisch, Wiley, neu, E-Book, elektronischer Download.
Lieferung aus: Vereinigte Staaten von Amerika, In Stock.
Can today's innovative practices and molecular tools tame this ancient disease? One third of the world's population is infected with tuberculosis (TB), with about 10 million new cases annually. To combat TB and its agent, Mycobacterium tuberculosis, the World Health Organization launched The End TB Strategy, which aims to slash the suffering and cost of TB by 2035. This makes the second edition of Tuberculosis and the Tubercle Bacillus, edited by Jacobs, McShane, Mizrahi, and Orme, an extremely valuable resource for scientists and clinicians. The editors have gathered their colleagues from around the world to present the latest on the molecular biology of M. tuberculosis and related species, the host-pathogen interactions that enable invasion, and the host's immune response to M. tuberculosis infection. The basic, clinical, and translational research presented in this book supports the goals of WHO's End TB Strategy by driving toward the development of effective vaccines, rapid molecular diagnostics, and anti-TB drugs. Creating an effective tuberculosis vaccine. Understand the innate and adaptive immune response to M. tuberculosis infection, its study in established animal models, and how this information is being used to develop new vaccines against TB. Formulating new antituberculosis drugs. Learn the challenges and methods for evaluating new drugs in preclinical trials with a focus on drugs that work against persisters and those that act on the electron transport complex and ATP synthase of M. tuberculosis. Overcoming the challenges of diagnosing tuberculosis. Review new diagnostic tools that are simple, rapid, affordable, specific, sensitive, and safe, including molecular-based diagnostic methods such as GeneXpert MTB/RIF. Using molecular, genomic, and bioinformatics tools to understand the biology and evolution of Mycobacterium. Explore current research on the molecular mechanisms that M. tuberculosis uses to evade the immune system, enter a state of nonreplicating persistence, and become reactivated. The second edition of Tuberculosis and the Tubercle Bacillus presents the latest research on a microorganism that is exquisitely well adapted to its human host. This pathogen continues to confound scientists, clinicians, and public health specialists, who will all find much valuable information in this comprehensive set of reviews.
Can today's innovative practices and molecular tools tame this ancient disease? One third of the world's population is infected with tuberculosis (TB), with about 10 million new cases annually. To combat TB and its agent, Mycobacterium tuberculosis, the World Health Organization launched The End TB Strategy, which aims to slash the suffering and cost of TB by 2035. This makes the second edition of Tuberculosis and the Tubercle Bacillus, edited by Jacobs, McShane, Mizrahi, and Orme, an extremely valuable resource for scientists and clinicians. The editors have gathered their colleagues from around the world to present the latest on the molecular biology of M. tuberculosis and related species, the host-pathogen interactions that enable invasion, and the host's immune response to M. tuberculosis infection. The basic, clinical, and translational research presented in this book supports the goals of WHO's End TB Strategy by driving toward the development of effective vaccines, rapid molecular diagnostics, and anti-TB drugs. Creating an effective tuberculosis vaccine. Understand the innate and adaptive immune response to M. tuberculosis infection, its study in established animal models, and how this information is being used to develop new vaccines against TB. Formulating new antituberculosis drugs. Learn the challenges and methods for evaluating new drugs in preclinical trials with a focus on drugs that work against persisters and those that act on the electron transport complex and ATP synthase of M. tuberculosis. Overcoming the challenges of diagnosing tuberculosis. Review new diagnostic tools that are simple, rapid, affordable, specific, sensitive, and safe, including molecular-based diagnostic methods such as GeneXpert MTB/RIF. Using molecular, genomic, and bioinformatics tools to understand the biology and evolution of Mycobacterium. Explore current research on the molecular mechanisms that M. tuberculosis uses to evade the immune system, enter a state of nonreplicating persistence, and become reactivated. The second edition of Tuberculosis and the Tubercle Bacillus presents the latest research on a microorganism that is exquisitely well adapted to its human host. This pathogen continues to confound scientists, clinicians, and public health specialists, who will all find much valuable information in this comprehensive set of reviews.
3
Tuberculosis and the Tubercle Bacillus
EN NW EB DLISBN: 9781555819569 bzw. 1555819567, in Englisch, neu, E-Book, elektronischer Download.
Lieferung aus: Vereinigte Staaten von Amerika, In Stock, plus shipping.
Can today's innovative practices and molecular tools tame this ancient disease? One third of the world's population is infected with tuberculosis (TB), with about 10 million new cases annually. To combat TB and its agent, Mycobacterium tuberculosis, the World Health Organization launched The End TB Strategy, which aims to slash the suffering and cost of TB by 2035. This makes the second edition of Tuberculosis and the Tubercle Bacillus, edited by Jacobs, McShane, Mizrahi, and Orme, an extremely valuable resource for scientists and clinicians. The editors have gathered their colleagues from around the world to present the latest on the molecular biology of M. tuberculosis and related species, the host-pathogen interactions that enable invasion, and the host's immune response to M. tuberculosis infection. The basic, clinical, and translational research presented in this book supports the goals of WHO's End TB Strategy by driving toward the development of effective vaccines, rapid molecular diagnostics, and anti-TB drugs. Creating an effective tuberculosis vaccine. Understand the innate and adaptive immune response to M. tuberculosis infection, its study in established animal models, and how this information is being used to develop new vaccines against TB. Formulating new antituberculosis drugs. Learn the challenges and methods for evaluating new drugs in preclinical trials with a focus on drugs that work against "persisters" and those that act on the electron transport complex and ATP synthase of M. tuberculosis. Overcoming the challenges of diagnosing tuberculosis. Review new diagnostic tools that are simple, rapid, affordable, specific, sensitive, and safe, including molecular-based diagnostic methods such as GeneXpert MTB/RIF. Using molecular, genomic, and bioinformatics tools to understand the biology and evolution of Mycobacterium. Explore current research on the molecular mechanisms that M. tuberculosis uses to evade the immune system, enter a state of nonreplicating persistence, and become reactivated. The second edition of Tuberculosis and the Tubercle Bacillus presents the latest research on a microorganism that is exquisitely well adapted to its human host. This pathogen continues to confound scientists, clinicians, and public health specialists, who will all find much valuable information in this comprehensive set of reviews.
Can today's innovative practices and molecular tools tame this ancient disease? One third of the world's population is infected with tuberculosis (TB), with about 10 million new cases annually. To combat TB and its agent, Mycobacterium tuberculosis, the World Health Organization launched The End TB Strategy, which aims to slash the suffering and cost of TB by 2035. This makes the second edition of Tuberculosis and the Tubercle Bacillus, edited by Jacobs, McShane, Mizrahi, and Orme, an extremely valuable resource for scientists and clinicians. The editors have gathered their colleagues from around the world to present the latest on the molecular biology of M. tuberculosis and related species, the host-pathogen interactions that enable invasion, and the host's immune response to M. tuberculosis infection. The basic, clinical, and translational research presented in this book supports the goals of WHO's End TB Strategy by driving toward the development of effective vaccines, rapid molecular diagnostics, and anti-TB drugs. Creating an effective tuberculosis vaccine. Understand the innate and adaptive immune response to M. tuberculosis infection, its study in established animal models, and how this information is being used to develop new vaccines against TB. Formulating new antituberculosis drugs. Learn the challenges and methods for evaluating new drugs in preclinical trials with a focus on drugs that work against "persisters" and those that act on the electron transport complex and ATP synthase of M. tuberculosis. Overcoming the challenges of diagnosing tuberculosis. Review new diagnostic tools that are simple, rapid, affordable, specific, sensitive, and safe, including molecular-based diagnostic methods such as GeneXpert MTB/RIF. Using molecular, genomic, and bioinformatics tools to understand the biology and evolution of Mycobacterium. Explore current research on the molecular mechanisms that M. tuberculosis uses to evade the immune system, enter a state of nonreplicating persistence, and become reactivated. The second edition of Tuberculosis and the Tubercle Bacillus presents the latest research on a microorganism that is exquisitely well adapted to its human host. This pathogen continues to confound scientists, clinicians, and public health specialists, who will all find much valuable information in this comprehensive set of reviews.
4
Tuberculosis and the Tubercle Bacillus
~EN NW EB DLISBN: 9781683673057 bzw. 1683673050, vermutlich in Englisch, John Wiley & Sons, neu, E-Book, elektronischer Download.
Tuberculosis and the Tubercle Bacillus: Can today`s innovative practices and molecular tools tame this ancient disease One third of the world`s population is infected with tuberculosis (TB), with about 10 million new cases annually. To combat TB and its agent, Mycobacterium tuberculosis, the World Health Organization launched The End TB Strategy, which aims to slash the suffering and cost of TB by 2035.This makes the second edition of Tuberculosis and the Tubercle Bacillus, edited by Jacobs, McShane, Mizrahi, and Orme, an extremely valuable resource for scientists and clinicians. The editors have gathered their colleagues from around the world to present the latest on the molecular biology of M. tuberculosis and related species, the host-pathogen interactions that enable invasion, and the host`s immune response to M. tuberculosis infection. The basic, clinical, and translational research presented in this book supports the goals of WHO`s End TB Strategy by driving toward the development of effective vaccines, rapid molecular diagnostics, and anti-TB drugs.\* Creating an effective tuberculosis vaccine. Understand the innate and adaptive immune response to M. tuberculosis infection, its study in established animal models, and how this information is being used to develop new vaccines against TB.\* Formulating new antituberculosis drugs. Learn the challenges and methods for evaluating new drugs in preclinical trials with a focus on drugs that work against `persisters` and those that act on the electron transport complex and ATP synthase of M. tuberculosis.\* Overcoming the challenges of diagnosing tuberculosis. Review new diagnostic tools that are simple, rapid, affordable, specific, sensitive, and safe, including molecular-based diagnostic methods such as GeneXpert MTB/RIF.\* Using molecular, genomic, and bioinformatics tools to understand the biology and evolution of Mycobacterium. Explore current research on the molecular mechanisms that M. tuberculosis uses to evade the immune system, enter a state of nonreplicating persistence, and become reactivated.The second edition of Tuberculosis and the Tubercle Bacillus presents the latest research on a microorganism that is exquisitely well adapted to its human host. This pathogen continues to confound scientists, clinicians, and public health specialists, who will all find much valuable information in this comprehensive set of reviews. Englisch, Ebook.
5
Symbolbild
Tuberculosis and the Tubercle Bacillus
~EN NW EB DLISBN: 9781555819569 bzw. 1555819567, vermutlich in Englisch, John Wiley & Sons, neu, E-Book, elektronischer Download.
Tuberculosis and the Tubercle Bacillus: Can today`s innovative practices and molecular tools tame this ancient disease One third of the world`s population is infected with tuberculosis (TB), with about 10 million new cases annually. To combat TB and its agent, Mycobacterium tuberculosis, the World Health Organization launched The End TB Strategy, which aims to slash the suffering and cost of TB by 2035.This makes the second edition of Tuberculosis and the Tubercle Bacillus, edited by Jacobs, McShane, Mizrahi, and Orme, an extremely valuable resource for scientists and clinicians. The editors have gathered their colleagues from around the world to present the latest on the molecular biology of M. tuberculosis and related species, the host-pathogen interactions that enable invasion, and the host`s immune response to M. tuberculosis infection. The basic, clinical, and translational research presented in this book supports the goals of WHO`s End TB Strategy by driving toward the development of effective vaccines, rapid molecular diagnostics, and anti-TB drugs.\* Creating an effective tuberculosis vaccine. Understand the innate and adaptive immune response to M. tuberculosis infection, its study in established animal models, and how this information is being used to develop new vaccines against TB.\* Formulating new antituberculosis drugs. Learn the challenges and methods for evaluating new drugs in preclinical trials with a focus on drugs that work against `persisters` and those that act on the electron transport complex and ATP synthase of M. tuberculosis.\* Overcoming the challenges of diagnosing tuberculosis. Review new diagnostic tools that are simple, rapid, affordable, specific, sensitive, and safe, including molecular-based diagnostic methods such as GeneXpert MTB/RIF.\* Using molecular, genomic, and bioinformatics tools to understand the biology and evolution of Mycobacterium. Explore current research on the molecular mechanisms that M. tuberculosis uses to evade the immune system, enter a state of nonreplicating persistence, and become reactivated.The second edition of Tuberculosis and the Tubercle Bacillus presents the latest research on a microorganism that is exquisitely well adapted to its human host. This pathogen continues to confound scientists, clinicians, and public health specialists, who will all find much valuable information in this comprehensive set of reviews. Englisch, Ebook.
6
Tuberculosis and the Tubercle Bacillus
ENISBN: 9781555812959 bzw. 1555812953, in Englisch, ASM Press.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd.
Tuberculosis and the Tubercle Bacillus Cole, Stewart T. / Eisenach, Kathleen D. / McMurray, David N. - Reviews state-of-the-art corpus of knowledge in this critical area of global health research - Provides clinical and epidemiological features of the disease-causing strains of Mycobacterium tuberculosis - Explores the genetics, genomics, cell structure, and metabolism of M. tuberculosis - Examines various animal models and their roles in vaccine development and testing - Features contributors who are world leaders in the field of tuberculosis research.
Tuberculosis and the Tubercle Bacillus Cole, Stewart T. / Eisenach, Kathleen D. / McMurray, David N. - Reviews state-of-the-art corpus of knowledge in this critical area of global health research - Provides clinical and epidemiological features of the disease-causing strains of Mycobacterium tuberculosis - Explores the genetics, genomics, cell structure, and metabolism of M. tuberculosis - Examines various animal models and their roles in vaccine development and testing - Features contributors who are world leaders in the field of tuberculosis research.
7
Tuberculosis and the Tubercle Bacillus
EN NWISBN: 9781555812959 bzw. 1555812953, in Englisch, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, in-stock.
The World Health Organization declared tuberculosis a global health emergency, and despite efforts toward eradication, the situation has intensified. Social and operational factors, including the growing AIDS epidemic and increasing drug resistance, have dramatically compounded the tuberculosis crisis. Tuberculosis and the Tubercle Bacillus, an extension of the 1994 publication Tuberculosis, is a state?of?the?art review of the corpus of knowledge available to researchers in the field. Divided into three comprehensive sections, this new volume begins with an examination of the current issues related to tuberculosis, including clinical and epidemiological features of the disease?causing strains. Topics explored in the second section include genetics, genomics, cell structure, and metabolism of Mycobacterium tuberculosis. Tuberculosis and the Tubercle Bacillus concludes with a detailed discussion of the host?bacillus relationship and presents information on animal models and their roles in prevention of tuberculosis. Key Features Reviews state?of?the?art corpus of knowledge in this critical area of global health research Provides clinical and epidemiological features of the disease?causing strains of Mycobacterium tuberculosis. Explores the genetics, genomics, cell structure, and metabolism of M. tuberculosis Examines various animal models and their roles in vaccine development and testing Features contributors who are world leaders in the field of tuberculosis research.
The World Health Organization declared tuberculosis a global health emergency, and despite efforts toward eradication, the situation has intensified. Social and operational factors, including the growing AIDS epidemic and increasing drug resistance, have dramatically compounded the tuberculosis crisis. Tuberculosis and the Tubercle Bacillus, an extension of the 1994 publication Tuberculosis, is a state?of?the?art review of the corpus of knowledge available to researchers in the field. Divided into three comprehensive sections, this new volume begins with an examination of the current issues related to tuberculosis, including clinical and epidemiological features of the disease?causing strains. Topics explored in the second section include genetics, genomics, cell structure, and metabolism of Mycobacterium tuberculosis. Tuberculosis and the Tubercle Bacillus concludes with a detailed discussion of the host?bacillus relationship and presents information on animal models and their roles in prevention of tuberculosis. Key Features Reviews state?of?the?art corpus of knowledge in this critical area of global health research Provides clinical and epidemiological features of the disease?causing strains of Mycobacterium tuberculosis. Explores the genetics, genomics, cell structure, and metabolism of M. tuberculosis Examines various animal models and their roles in vaccine development and testing Features contributors who are world leaders in the field of tuberculosis research.
8
Symbolbild
Tuberculosis and the Tubercle Bacillus (2017)
EN HC NWISBN: 9781555819552 bzw. 1555819559, in Englisch, 2. Ausgabe, ASM Press, gebundenes Buch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Not yet published.
Von Händler/Antiquariat, Amazon.com.
Hardcover, Edition: 2, Label: ASM Press, ASM Press, Product group: Book, Published: 2017-07-01, Studio: ASM Press.
Von Händler/Antiquariat, Amazon.com.
Hardcover, Edition: 2, Label: ASM Press, ASM Press, Product group: Book, Published: 2017-07-01, Studio: ASM Press.
9
Editor: Stewart T. Cole, Editor: Kathleen Davis Eisenach, Editor: David N. McMurray, Editor: William R. Jr. Jacobs
Tuberculosis and the Tubercle Bacillus (2004)
EN HC NW FEISBN: 9781555812959 bzw. 1555812953, in Englisch, 584 Seiten, ASM Press, gebundenes Buch, neu, Erstausgabe.
Novo iz: $19.18 (22 Ponude)
Koristi od: $5.87 (14 Ponude)
Više detalja 36 Ponude na Amazon.com
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 1-2 business days.
Von Händler/Antiquariat, TheBookCellar-NH.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Von Händler/Antiquariat, TheBookCellar-NH.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
10
Tuberculosis And The Tubercle Bacillus
EN NWISBN: 9781555819552 bzw. 1555819559, in Englisch, AMERICAN SOCIETY MICR, neu.
Lieferung aus: Kanada, In Stock, plus shipping.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…